Despite expected EPS growth, Harmony Biosciences' low P/E ra...

Despite expected EPS growth, Harmony Biosciences' low P/E ratio signals bearishness as skeptics question its ability to improve declining earnings, potentially capping its stock price. The P/E and growth outlook mismatch suggests investor concerns about unexpected earnings threats.